Pancreatic cancer: failures and hopes—a review of new promising treatment approaches
Pancreatic cancer is a challenging disease with limited treatment options and a high mortality rate. Just few therapy advances have been made in recent years. Tumor microenvironment, immunosuppressive features and mutational status represent important obstacles in the improvement of survival outcome...
Saved in:
| Main Authors: | Vittore Cereda, Mario Rosario D’Andrea |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2025-03-01
|
| Series: | Exploration of Targeted Anti-tumor Therapy |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A1002299/1002299.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer
by: Nawaz Khan, et al.
Published: (2025-07-01) -
Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?
by: Shenao Fu, et al.
Published: (2025-07-01) -
Unraveling the glyco-immunity nexus in pancreatic cancer
by: Christabelle Rajesh, et al.
Published: (2025-08-01) -
Immunotherapy for Platinum-Resistant Ovarian Cancer as a Glimmer of Hope
by: Jan Brancewicz, et al.
Published: (2025-06-01) -
Immunosenescence-Related Gene MAFF is Involved in Immune Regulation and Malignant Progression in Pancreatic Adenocarcinoma
by: Fenglin Zhang, et al.
Published: (2025-07-01)